Literature DB >> 6438122

A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography.

R A Hawkins, M E Phelps, S C Huang, J A Wapenski, P D Grimm, R G Parker, G Juillard, P Greenberg.   

Abstract

Twelve patients with primary and metastatic brain tumors were evaluated with [68Ga]ethylenediaminetetraacetate (EDTA) and positron computed tomography. Using a two-compartment tracer kinetic model, forward (K1) and reverse (k2) rate constants for molecular diffusion across the blood-brain barrier (BBB) were obtained and averaged 0.0029 +/- 0.0016 (mean +/- SD) ml/min/g for K1 and 0.0310 +/- 0.0156 min-1 for k2. Most tracer kinetic models are based on the assumption that tissue radioactivity contains no vascular component or require independent measures of cerebral blood volume (CBV) which are then subtracted from the measure tissue activity. The model in this work differs from that approach by assuming a vascular compartment in the tissue kinetic data. This vascular parameter is estimated from sequential measurements of activity concentrations in regions with an intact BBB or from measurements of 68Ga concentrations in the plasma (the input function). Thus, this approach does not require the assumption of a zero vascular contribution, does not require a separate measurement of CBV, and uses the criteria of constrained estimation to provide estimates of the local CBV and molecular diffusion through the BBB. Estimates of the relative CBV of the lesions in four studies (three subjects) with [68Ga]EDTA correlated well with those obtained with the C15O hemoglobin technique (correlation coefficient of 0.97).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438122     DOI: 10.1038/jcbfm.1984.75

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  A cerebral glioma model for experimental therapy and in vivo invasion studies in syngeneic BD IX rats.

Authors:  O Mella; R Bjerkvig; B C Schem; O Dahl; O D Laerum
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  Measurement of human blood brain barrier integrity using 11C-inulin and positron emission tomography.

Authors:  T Hara; M Iio; T Tsukiyama; F Yokoi
Journal:  Eur J Nucl Med       Date:  1988

3.  Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET.

Authors:  K Herholz
Journal:  Eur J Nucl Med       Date:  1988

4.  Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.

Authors:  Nanda C Krak; Jacobus J M van der Hoeven; Otto S Hoekstra; Jos W R Twisk; Elsken van der Wall; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

Review 5.  Brain tumors.

Authors:  K L Black; J C Mazziotta; D P Becker
Journal:  West J Med       Date:  1991-02

6.  Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.

Authors:  Yui-May Hsiao; Carla J Mathias; Shiaw-Pyng Wey; Phillip E Fanwick; Mark A Green
Journal:  Nucl Med Biol       Date:  2009-01       Impact factor: 2.408

7.  A method for quantitative measurement of cerebral vascular permeability using X-ray CT and iodinated contrast medium.

Authors:  T Terada; K Nambu; G Hyotani; K Miyamoto; M Tsuura; Y Nakamura; T Nishiguchi; T Itakura; S Hayashi; N Komai
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

8.  In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors.

Authors:  W T Yeung; T Y Lee; R F Del Maestro; R Kozak; T Brown
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

9.  Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.

Authors:  S Mitsuki; M Diksic; T Conway; Y L Yamamoto; J G Villemure; W Feindel
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

Review 10.  PET in clinical oncology.

Authors:  R A Hawkins; M E Phelps
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.